Literature DB >> 11128286

Synthesis of 2-Oxo amide triacylglycerol analogues and study of their inhibition effect on pancreatic and gastric lipases.

G Kokotos1, R Verger, A Chiou.   

Abstract

A general method for the synthesis of chiral 2-oxo amide triacylglycerol analogues, from (R)- or (S)-3-aminopropane-1,2-diol, was developed. These novel inhibitors of digestive lipases are analogues of the triacylglycerol molecule, a natural substrate of lipases, and they were designed to contain the 2-oxo amide functionality in place of the scissile ester bond at the sn-1 or sn-3 position and nonhydrolysable ether bonds instead of ester bonds at the other two remaining positions. The 2-oxo amide derivatives synthesised were tested for their ability to form stable monomolecular films at the air/water interface by recording their surface pressure/molecular area compression isotherms. The inhibition of porcine pancreatic and human gastric lipases by the 2-oxo amides was studied by means of the monolayer technique with mixed films of 1,2-dicaprin and with variable proportions of each inhibitor. The alpha50 values of these triacylglycerol analogues for PPL and HGL varied between 4.4 to 7.0% and 5.6 to 15.9%, respectively. The chirality at the sn-2 position of 2-oxo amide triacylglycerol analogues affected the alpha50 value for HGL, but not for PPL.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11128286     DOI: 10.1002/1521-3765(20001117)6:22<4211::aid-chem4211>3.0.co;2-#

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  Synthesis and characterization of a series of carbamate-linked cationic lipids for gene delivery.

Authors:  Dongliang Liu; Jianjun Hu; Weihong Qiao; Zongshi Li; Shubiao Zhan; Lvbo Cheng
Journal:  Lipids       Date:  2005-08       Impact factor: 1.880

2.  Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.

Authors:  Daren Stephens; Efrosini Barbayianni; Violetta Constantinou-Kokotou; Anna Peristeraki; David A Six; Jennifer Cooper; Richard Harkewicz; Raymond A Deems; Edward A Dennis; George Kokotos
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

3.  A novel formulation based on 2,3-di(tetradecyloxy)propan-1-amine cationic lipid combined with polysorbate 80 for efficient gene delivery to the retina.

Authors:  Gustavo Puras Ochoa; Jon Zárate Sesma; Mireia Agirre Díez; Ariadna Díaz-Tahoces; Marcelino Avilés-Trigeros; Santiago Grijalvo; Ramón Eritja; Eduardo Fernández; Jose Luis Pedraz
Journal:  Pharm Res       Date:  2014-01-22       Impact factor: 4.200

4.  Binding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics.

Authors:  Varnavas D Mouchlis; Vasiliki Michopoulou; Violetta Constantinou-Kokotou; Thomas Mavromoustakos; Edward A Dennis; George Kokotos
Journal:  J Chem Inf Model       Date:  2012-01-10       Impact factor: 4.956

5.  A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity.

Authors:  Victoria Magrioti; George Naxakis; Dimitra Hadjipavlou-Litina; Alexandros Makriyannis; George Kokotos
Journal:  Bioorg Med Chem Lett       Date:  2008-09-12       Impact factor: 2.823

6.  Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes.

Authors:  Georgia Antonopoulou; Efrosini Barbayianni; Victoria Magrioti; Naomi Cotton; Daren Stephens; Violetta Constantinou-Kokotou; Edward A Dennis; George Kokotos
Journal:  Bioorg Med Chem       Date:  2008-11-01       Impact factor: 3.641

7.  Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics.

Authors:  Keith Clinch; Gary B Evans; Richard F G Fröhlich; Shivali A Gulab; Jemy A Gutierrez; Jennifer M Mason; Vern L Schramm; Peter C Tyler; Anthony D Woolhouse
Journal:  Bioorg Med Chem       Date:  2012-07-14       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.